# Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tau-centric-targets-and-drugs-in-clinical-development-for-the-treatment-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Panza,Vincenzo Solfrizzi,Davide Seripa,Bruno P. Imbimbo,Madia Lozupone,Andrea Santamato,Chiara Zecca,Maria Rosaria Barulli,Antonello Bellomo,Alberto Pilotto,Antonio Daniele,Antonio Greco,Giancarlo Logroscino |
| Citations | 190 |
| DOI | 10.1155/2016/3245935 |
| Fields | Computer Science,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://downloads.hindawi.com/journals/bmri/2016/3245935.pdf |
| OpenAlex ID | https://openalex.org/W2463554686 |
| PMID | 27429978 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Francesco Panza](https://scholariq.org/researchers/francesco-panza/)
- [Vincenzo Solfrizzi](https://scholariq.org/researchers/vincenzo-solfrizzi/)
- [Antonello Bellomo](https://scholariq.org/researchers/antonello-bellomo/)
- [Antonio Greco](https://scholariq.org/researchers/antonio-greco/)
- [Alberto Pilotto](https://scholariq.org/researchers/alberto-pilotto/)

## Paper journal

- [BioMed Research International](https://scholariq.org/journals/biomed-research-international/)

## Paper primary topic

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Paper topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.